Fizazi, A. (2024) “High BRAF V600 Mutation Level Associated with Worse Outcome in Metastatic Melanoma Patients Receiving BRAF and MEK Inhibitors”, Acta Dermato-Venereologica, 104, p. adv40913. doi: 10.2340/actadv.v104.40913.